Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet function tests in thalassemic children.

P Isarangkura1, P Pintadit, P Hathirat

  • 1Department of Pediatrics, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Birth Defects Original Article Series
|January 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of factor VIII and factor IX mutations, HLA Class II, tumour necrosis factor-α and interleukin-10 on inhibitor development among Thai haemophilia A and B patients.

Haemophilia : the official journal of the World Federation of Hemophilia·2017
Same author

Prenatal diagnosis for haemophilia: the Thai experience.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Disarticulation of a knee joint in a haemophiliac with high inhibitor titre.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Safety and efficacy of recombinant activated factor VII for long-term secondary prophylaxis in a haemophilia boy with high-titre inhibitors.

Haemophilia : the official journal of the World Federation of Hemophilia·2013
Same author

Simple and accurate bedside diagnostic kit for determining haemophilia A and B: a revised version.

Haemophilia : the official journal of the World Federation of Hemophilia·2012
Same author

Accurate bedside diagnostic kit for determining haemophilia A and B.

Haemophilia : the official journal of the World Federation of Hemophilia·2008

Platelet function in thalassemia varies, showing hyperaggregation or hypoaggregation, impacting bleeding risk. These platelet changes correlate with disease severity and may necessitate antiplatelet therapy in specific patient groups.

Area of Science:

  • Hematology
  • Thrombosis Research

Background:

  • Thalassemia is a group of inherited blood disorders characterized by reduced hemoglobin production.
  • Platelet dysfunction is frequently observed in thalassemia patients, but its specific nature and clinical implications require further elucidation.

Purpose of the Study:

  • To investigate the spectrum of platelet alterations in patients with thalassemia.
  • To correlate observed platelet changes with disease severity and clinical outcomes, such as bleeding and thrombocytosis.

Main Methods:

  • Analysis of platelet parameters including bleeding time, platelet count (thrombocytosis), platelet retention, PF3 release, and platelet aggregation.
  • Categorization of platelet aggregation into hyperaggregation, normal, and hypoaggregation.

Main Results:

Related Experiment Videos

  • Significant findings include prolonged bleeding time (30%), thrombocytosis (29%), and decreased platelet retention (79%).
  • Platelet aggregation patterns varied, with 50% showing hyperaggregation, 22% normal, and 28% hypoaggregation.
  • Platelet hypoaggregation was linked to bleeding issues, while hyperaggregation and thrombocytosis were prominent in splenectomized and/or severely anemic patients.

Conclusions:

  • Platelet function in thalassemia is heterogeneous, encompassing hyper-, normal, and hypo-functional states.
  • Disease progression significantly influences these platelet changes.
  • Identifying specific platelet dysfunction patterns may guide therapeutic interventions, including the potential use of antiplatelet drugs in high-risk individuals.